A detailed history of Dimensional Fund Advisors LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,643,404 shares of NVO stock, worth $144 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,643,404
Previous 1,619,739 1.46%
Holding current value
$144 Million
Previous $231 Million 15.36%
% of portfolio
0.05%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$119.07 - $145.42 $2.82 Million - $3.44 Million
23,665 Added 1.46%
1,643,404 $196 Million
Q2 2024

Aug 09, 2024

SELL
$122.71 - $146.91 $15.8 Million - $18.9 Million
-128,604 Reduced 7.36%
1,619,739 $231 Million
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $2.7 Million - $3.6 Million
-26,456 Reduced 1.49%
1,748,343 $224 Million
Q4 2023

Feb 07, 2024

SELL
$87.78 - $105.45 $310,302 - $372,765
-3,535 Reduced 0.2%
1,774,799 $184 Million
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $82.9 Million - $182 Million
911,761 Added 105.21%
1,778,334 $162 Million
Q2 2023

Aug 09, 2023

BUY
$155.98 - $172.65 $3.48 Million - $3.85 Million
22,309 Added 2.64%
866,573 $140 Million
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $634,173 - $762,598
4,792 Added 0.57%
844,264 $134 Million
Q4 2022

Feb 09, 2023

BUY
$102.55 - $135.33 $5.63 Million - $7.43 Million
54,872 Added 6.99%
839,472 $114 Million
Q3 2022

Nov 10, 2022

BUY
$95.28 - $116.93 $2.09 Million - $2.57 Million
21,979 Added 2.88%
784,600 $78.2 Million
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $2.38 Million - $2.81 Million
23,036 Added 3.11%
762,621 $85 Million
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $642,669 - $776,863
6,903 Added 0.94%
739,585 $82.1 Million
Q4 2021

Feb 09, 2022

BUY
$95.88 - $117.08 $1.65 Million - $2.01 Million
17,178 Added 2.4%
732,682 $82.1 Million
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $40,099 - $50,644
475 Added 0.07%
715,504 $68.7 Million
Q2 2021

Aug 12, 2021

SELL
$67.66 - $84.76 $1.32 Million - $1.66 Million
-19,536 Reduced 2.66%
715,029 $59.9 Million
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $544,124 - $615,203
-8,114 Reduced 1.09%
734,565 $49.5 Million
Q4 2020

Feb 25, 2021

BUY
$63.89 - $73.8 $47.4 Million - $54.8 Million
742,679 New
742,679 $51.9 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.